Cardiopulmonary Stress Testing Systems Market size is expected to reach USD 15 Billion by the end of 2036, growing at a CAGR of 5% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of cardiopulmonary stress testing systems was USD 7 Billion. Rapid increase in frequency of cardiovascular diseases is fueling the expansion of the market. According to WHO, around 17.9 million people die worldwide due to cardiovascular diseases. Moreover, four out of five deaths are caused due to heart attacks and strokes, and one third occur prematurely in population under 70 years of age.
People are changing their lifestyles and adopting new habits for improving health conditions including cutting down the use of tobacco, reducing the consumption of salt in the diet, eating more fruit and vegetables, regular physical activity, and avoiding alcohol.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~5% |
|
Base Year Market Size (2023) |
~ USD 7 Billion |
|
Forecast Year Market Size (2036) |
~ USD 15 Billion |
|
Regional Scope |
|
Product Type (Cardiopulmonary exercise testing (CPET) systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors)
The cardiopulmonary exercise testing (CPET) systems segment is predicted to account for 35% share of the global cardiopulmonary stress testing systems market by 2036. The segment growth can be attributed to the precision and quick operation while diagnosis. Moreover, cost-effectiveness and usage in different places have increased the preference between doctors and patients. CPET system provides recognizable and complimentary evaluation by providing a more accurate and reliable measurement of a patient’s functional capacity. For instance, a report was published in 2023 which states that CPET is a safe process having the risk of death for patients between 2 and 5 per 100,000 exercise tests performed.
End-User (Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers)
The hospital segment is predicted to account for 37% share of the global cardiopulmonary stress testing systems market by 2036. The segment growth can be attributed to the government policies adopted to increase admissions in hospitals for cardiovascular diseases. People prefer hospital-based treatments as they provide early diagnosis and stress testing procedures are widely adopted at these facilities. Hospitals provide top-quality medical care to patients without any complications for existing patients.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
Application |
|
|
End-User |
|
North America Market Forecast
The cardiopulmonary stress testing systems market in North America is anticipated to hold the largest with a share of about 34% by the end of 2036. The market growth in the region is also expected on account of a rise in hospital admissions, the deployment of novel products by healthcare facilities, efficiency in the early detection of cardiovascular diseases and increase in the number of cardiac specialty centers. Moreover, the latest cardiac care services and huge investment by the government in the healthcare sector are leading to regional growth. Skilled doctors are available on a large scale for treating patients as the rate of heart disease is very high in the region. Various private and government organizations are taking initiatives including program launches and funding for raising awareness among people. For instance, a report published by the American Heart Association in 2020 states that around 28 million non-cardiac surgical procedures are performed in the United States every year. The introduction of cardiopulmonary stress testing systems can help fight heart diseases and reduce mortality rates.
European Market Analysis
The Europe cardiopulmonary stress testing systems market is estimated to be the second largest, registering a share of about 23% by the end of 2036. The market’s expansion can be attributed majorly to the increasing demand for cardiovascular disease monitoring, diagnostic machines and rising awareness of stress testing are the factors fueling the regional growth. During the pandemic, some European Union member states were under high pressure as the number of patients increased which resulted in a shortage of staff in hospitals and daycare centers. The patients were highly infected and were under quarantine which hindered easy access to medical services due to travel restrictions. According to the European Union, around 37,200 heart bypass surgeries were conducted in Germany in 2021 and 17,400 were conducted in France. Moreover, the rise in adoption and invasion of the latest testing systems at hospitals and institutions that instruct doctors and nurses in monitoring patients’ health accelerate the development of testing systems.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?